Table 1.
Demographics | Readmit n (%) |
No Readmit n (%) |
p-value |
---|---|---|---|
Age | |||
65–69 | 110 (34%) | 422 (34%) | 0.916 |
70–74 | 102 (32%) | 410 (34%) | |
75–79 | 71 (22%) | 249 (20%) | |
80–84 | 24 (8%) | 119 (10%) | |
85+ | 12 (4%) | 24 (2%) | |
Sex | |||
Female | 71 (22%) | 228 (19%) | 0.726 |
Year of Diagnosis | |||
2000–2001 | 57 (18%) | 219 (18%) | 0.983 |
2002–2003 | 59 (18%) | 241 (20%) | |
2004–2005 | 74 (23%) | 295 (24%) | |
2006–2007 | 65 (20%) | 258 (21%) | |
2008–2009 | 64 (20%) | 211 (17%) | |
Tumor Stage | |||
0 | 10 (3%) | 36 (3%) | 0.990 |
I | 99 (32%) | 412 (34%) | |
II | 124 (40%) | 484 (40%) | |
III | 55 (18%) | 196 (16%) | |
IV | 22 (7%) | 71 (6%) | |
Comorbidities | |||
Induction chemotherapy | 137 (43%) | 445 (36%) | 0.032 |
COPD | 41 (13%) | 98 (8%) | 0.011 |
Diabetes | 32 (10%) | 167 (14%) | 0.092 |
Congestive heart failure | 7 (2%) | 34 (3%) | 0.697 |
Myocardial infarction | 5 (2%) | 10 (1%) | 0.212 |
Peripheral vascular disease | 8 (3%) | 18 (1%) | 0.220 |
COPD: Chronic obstructive pulmonary disease